Prices are updated after-hours

Nasdaq 5

Technicolor

TCLRY | $0.001 1000.0% 140K

(0.0% 1d) (0.0% 1m) (-91.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (482.33% volume)
Earnings Calendar:
Market Cap: $ 9,596,094
https://www.technicolor.com/fr
Sec Filling | Patents | n/a employees

(FR)

add to watch list Paper trade email alert is off

Zealand Pharma A/S

ZEAL | $17.59 1.21% -4.21%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (1.2% 3d) (0.0% 7d) (22.0% volume)
Earnings Calendar:
Market Cap: $ 818,606,692
http://www.zealandpharma.com
Sec Filling | Patents | 179 employees

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.

add to watch list Paper trade email alert is off

ATLAS COPCO AB

ATLFF | News | $14.785 -39.21% 3.3K

Manufacturing

(0.0% 1d) (-1.8% 1m) (34.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-98.41% volume)
Earnings Calendar:
Market Cap: $ 23,077,552,133
https://www.atlascopco.com/
Sec Filling | Patents | n/a employees

(SE)

add to watch list Paper trade email alert is off

BeiGene, Ltd.

BEIGF | $14.29 -9.87% 2.1K

n/a

(0.0% 1d) (0.0% 1m) (-14.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (366.67% volume)
Earnings Calendar:
Market Cap: $ 18,387,425,502
http://www.beigene.com/
Sec Filling | Patents | 5300 employees

(China (Mainland)) beigene is a chinese life sciences biotechnology company based in beijing that is focused on discovering and developing innovative oncology drugs that will address unmet medical needs in cancers that are prevalent in china and the asia-pacific region.

add to watch list Paper trade email alert is off

Endo International plc

ENDP | $0.2926 -9.6%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (-5.0% 3d) (0.0% 7d) (97.63% volume)
Earnings Calendar: 2022-11-03
Market Cap: $ 68,802,809
http://www.endo.com
Sec Filling | Patents | 3172 employees

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland.

cardiovascular women health nervous system women brands msa injection

add to watch list Paper trade email alert is off

Medicenna Therapeutics Corp.

MDNA | $0.157 -0.32% 1.3M

Health Technology

(0.0% 1d) (0.0% 1m) (-74.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (167.34% volume)
Earnings Calendar: 2023-10-26
Market Cap: $ 10,933,083
http://www.medicenna.com
Sec Filling | Patents | 7 employees

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

cancer treatment

add to watch list Paper trade email alert is off

Beam Global

BEEM | $6.315 -1.33% 38K

Utilities

(0.0% 1d) (-22.6% 1m) (-45.1% 1y) (0.0% 2d) (0.0% 3d) (4.2% 7d) (-25.86% volume)
Earnings Calendar: 2024-04-16
Market Cap: $ 91,177,675
http://beamforall.com
Sec Filling | Patents | 35 employees

Beam Global engages in the invention, design, engineering, manufacture, and sale of solar powered products. It offers solar powered products and proprietary technology solutions for electric vehicle charging infrastructure, out of home advertising platforms, and energy security and disaster preparedness. The company was founded by Robert Lane Noble on June 12, 2006 and is headquartered in San Diego, CA.

energy vehicles solar eletric vehicle security electric vehicles eletrical

add to watch list Paper trade email alert is off

Foresight Autonomous Holdings Ltd.

FRSX | $1.05 21K

Finance

(0.0% 1d) (8.2% 1m) (-42.1% 1y) (0.0% 2d) (-7.9% 3d) (-9.5% 7d) (-35.76% volume)
Earnings Calendar:
Market Cap: $ 11,367,232
http://www.foresightauto.com
Sec Filling | Patents | 70 employees

(IL) Foresight Autonomous Holdings Ltd. engages in the research and development of vehicular accident prevention products. Its product is QuadSight, a multi-spectral vision solution for detection of obstacles in harsh lightining and weather conditions. The company was founded by Haim Siboni on September 19, 1977 and is headquartered in Ness Ziona, Israel.

autonomous lidar israel

add to watch list Paper trade email alert is off

Nikola Corporation

NKLA | $0.6706 1.61% 16M

Consumer Durables

(0.0% 1d) (1.7% 1m) (-29.7% 1y) (0.0% 2d) (0.0% 3d) (-2.1% 7d) (-25.87% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 895,663,530
http://www.nikolamotor.com
Sec Filling | Patents | 256 employees

(US) Nikola Corp. engages in the provision of zero-emissions transportation and infrastructure solutions. It designs and manufactures battery-electric and hydrogen-electric vehicles, electric vehicle drivetrains, vehicle components, energy storage systems, and hydrogen fueling station infrastructure. The company was founded by Trevor Milton in 2015 and is headquartered in Phoenix, AZ.

energy hydrogen vehicles eletric vehicle batteries battery electric vehicles eletrical

add to watch list Paper trade email alert is off

Maris Tech Ltd.

MTEK | $1.5 9.9K

(0.0% 1d) (13.4% 1m) (93.8% 1y) (0.0% 2d) (0.0% 3d) (-5.9% 7d) (-45.64% volume)
Earnings Calendar:
Market Cap: $ 11,817,752

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

Icecure Medical Ltd

ICCM | $1.23 41K

Manufacturing

(0.0% 1d) (7.9% 1m) (-8.2% 1y) (0.0% 2d) (0.0% 3d) (-5.1% 7d) (69.03% volume)
Earnings Calendar: 2023-08-14
Market Cap: $ 56,116,824
https://icecure-medical.com
Sec Filling | Patents | n/a employees

Founded in 2006, Israel-based IceCure Medical develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally-invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide, after receiving FDA and CE approvals.

treatment cancer urea israel kidney lung cancer lungs

add to watch list Paper trade email alert is off

Appian Corporation

APPN | $34.915 0.16% 46K

Technology Services

(0.0% 1d) (-3.7% 1m) (-8.5% 1y) (0.0% 2d) (0.0% 3d) (-3.9% 7d) (-17.05% volume)
Earnings Calendar: 2024-02-15
Market Cap: $ 1,473,562,576
http://www.appian.com
Sec Filling | Patents | 1018 employees

(US) Appian Corp. provides business process management (BPM) solutions. Its BPM tools automate and measures business processes. The firm's products include BPM software, case management, mobile application development, and platform-as-a-service. The company was founded by Matt Calkins, Robert C. Kramer, Marc Wilson, and Michael Beckley in 1999 and is headquartered in Reston, V A.

msa

add to watch list Paper trade email alert is off

Integral Ad Science Holding Corp

IAS | $9.22 1.32% 380K

(0.0% 1d) (-3.2% 1m) (-37.5% 1y) (0.0% 2d) (0.0% 3d) (-1.8% 7d) (-2.2% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 1,473,000,606
https://integralads.com
Sec Filling | Patents | 651 employees

Integral Ad Science (IAS) is a global leader in digital media quality. IAS makes every impression count, ensuring that ads are viewable by real people, in safe and suitable environments, activating contextual targeting, and driving supply path optimization. Its mission is to be the global benchmark for trust and transparency in digital media quality for the world's leading brands, publishers, and platforms. IAS does this through data-driven technologies with actionable real-time signals and insight. Founded in 2009 and headquartered in New York, IAS works with thousands of top advertisers and premium publishers worldwide.

optical brands

add to watch list Paper trade email alert is off

AdTheorent Holding Company Inc

ADTH | $3.2 0.31% 230K

(0.0% 1d) (-2.7% 1m) (119.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-49.1% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 290,893,786

Sec Filling | Patents | 4 employees

add to watch list Paper trade email alert is off

T2 Biosystems, Inc.

TTOO A | $2.99 12K

Health Technology

(0.0% 1d) (-5.5% 1m) (705.5% 1y) (0.0% 2d) (0.0% 3d) (-1.0% 7d) (-24.38% volume)
Earnings Calendar: 2024-04-01
Market Cap: $ 16,481,873
http://www.t2biosystems.com
Sec Filling | Patents | 151 employees

(US) T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

magnetic resonance pathogens

add to watch list Paper trade email alert is off

Workday, Inc.

WDAY S | $253.55 -0.82% 230K

Technology Services

(0.0% 1d) (-7.0% 1m) (34.5% 1y) (0.0% 2d) (0.0% 3d) (-1.0% 7d) (-38.69% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 53,499,050,000
http://www.workday.com
Sec Filling | Patents | 12200 employees

(US) Workday, Inc. engages in the development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in March 2005 and is headquartered in Pleasanton, CA.

education

add to watch list Paper trade email alert is off

Compass Therapeutics Inc

CMPX | $1.49 71K

Professional, Scientific, and T...

(0.0% 1d) (-25.9% 1m) (-43.5% 1y) (0.0% 2d) (0.0% 3d) (2.3% 7d) (Infinity% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 205,007,865

Sec Filling | Patents | 26 employees

compass therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals, and engineered protein constructs. compass is industrializing antibody discovery and decentralizing biologic validation through a partnership-first mentality that leverages best-in-class technologies and top-tier academic laboratories around the world. novel scientific insights are validated and explored deeply inside our labs before compass pursues the best proprietary combinations of therapeutics into human clinical trials. in 2015, compass quietly closed a $120mm series a financing to fund our ambitious plan to build a fully-integrated biopharmaceutical company from the ground up. our investors are among the most sophisticated venture capitalists in the industry who exemplify our philosophy of building long term economic value only by delivering therapeutics with meaningful efficacy beyond

add to watch list Paper trade email alert is off

Jeffs' Brands Ltd

JFBR | $0.311 8.4K

n/a

(0.0% 1d) (-13.9% 1m) (-62.9% 1y) (0.0% 2d) (0.0% 3d) (-0.2% 7d) (22.52% volume)
Earnings Calendar:
Market Cap: $ 964,092

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

PAVmed Inc.

PAVM | $1.95 5.1K

Health Technology

(0.0% 1d) (-10.9% 1m) (251.8% 1y) (0.0% 2d) (0.0% 3d) (3.1% 7d) (45.76% volume)
Earnings Calendar: 2023-11-14
Market Cap: $ 17,886,045
http://www.pavmed.com
Sec Filling | Patents | 15 employees

PAVmed, Inc. is a medical device company, which develops and commercializes a pipeline of medical products. Its product portfolio includes DisappEAR, PORTIO, Caldus, Carpx, NextCath, and NextFlo. The firm conducts its operations in four divisions: GI Health, Minimally Invasive Interventions, Infusion Therapy and Emerging Innovations. The GI Health division consists of Edouard Esophageal DNA Test, EsoCheck Esophageal Cell Collection Device, and EsoCure Esophageal Ablation Device with Caldus Technology. The Minimally Invasive Interventions division consists of CarpX, which is a patented, single-use disposable, minimally invasive device designed to treat carpal tunnel syndrome. The Infusion Therapy division consists of PortIO, which is a novel, patented, implantable, intraosseous vascular medical device; and NextFlo, which is designed to deliver gravity-driven infusions independent of the height of the IV bag. The Emerging Innovations division refers to a diversified and expanding portfolio of innovative products designed to address unmet clinical needs across a broad range of clinical conditions. The company was founded on June 26, 2014 and is headquartered in New York, NY.

t-cell ceiling

add to watch list Paper trade email alert is off

icad inc.

ICAD | $1.59 12K

Technology Services

(0.0% 1d) (0.6% 1m) (7.6% 1y) (0.0% 2d) (0.0% 3d) (-4.3% 7d) (-33.14% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 42,198,648
http://www.icadmed.com
Sec Filling | Patents | 138 employees

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment include image analysis and workflow products. The Cancer Therapy segment consists radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.

cancer radiation therapy

add to watch list Paper trade email alert is off